Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (431-440 of 480) with videos related to

Pageof 48
Sort By:
Science Advances|January 19, 2022
Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoidsPengfei Li, Yunlong Li, Yijin Wang, et al.
JHEP Reports : Innovation in Hepatology|October 3, 2022
Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinomaMonique T A de Beijer, Karel Bezstarosti, Robbie Luijten, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
BMJ Open Gastroenterology|April 19, 2024
Progression of the FIB-4 index among patients with chronic HCV infection and early liver diseaseLisette A P Krassenburg, Raoel Maan, Amy Puenpatom, et al.
Journal of Medicinal Chemistry|September 20, 2002
Unique overlap in the prerequisites for thrombin inhibition and oral bioavailability resulting in potent oral antithromboticsAnton E P Adang, Adrianus P A de Man, Gerard M T Vogel, et al.
Vaccine|May 26, 2009
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?R van Houdt, F D H Koedijk, S M Bruisten, et al.
Hepatology (Baltimore, Md.)|August 15, 2021
Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetableYang Li, Peifa Yu, Amy L Kessler, et al.
The Journal of Infectious Diseases|July 12, 2012
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIVRoeland Zoutendijk, Hans L Zaaijer, Theodora E M S de Vries-Sluijs, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Scientific Reports|July 25, 2019
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levelsKostandinos Sideras, Robert A de Man, Susan M Harrington, et al.
Pageof 48

Showing results (431-440 of 480) with videos related to

Sort By:
Pageof 48
Science Advances|January 19, 2022
Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoidsPengfei Li, Yunlong Li, Yijin Wang, et al.
JHEP Reports : Innovation in Hepatology|October 3, 2022
Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinomaMonique T A de Beijer, Karel Bezstarosti, Robbie Luijten, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosisMilan J Sonneveld, Willem P Brouwer, Bettina E Hansen, et al.
BMJ Open Gastroenterology|April 19, 2024
Progression of the FIB-4 index among patients with chronic HCV infection and early liver diseaseLisette A P Krassenburg, Raoel Maan, Amy Puenpatom, et al.
Journal of Medicinal Chemistry|September 20, 2002
Unique overlap in the prerequisites for thrombin inhibition and oral bioavailability resulting in potent oral antithromboticsAnton E P Adang, Adrianus P A de Man, Gerard M T Vogel, et al.
Vaccine|May 26, 2009
Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?R van Houdt, F D H Koedijk, S M Bruisten, et al.
Hepatology (Baltimore, Md.)|August 15, 2021
Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetableYang Li, Peifa Yu, Amy L Kessler, et al.
The Journal of Infectious Diseases|July 12, 2012
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIVRoeland Zoutendijk, Hans L Zaaijer, Theodora E M S de Vries-Sluijs, et al.
Hepatology (Baltimore, Md.)|December 10, 2009
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analoguesFlorian van Bömmel, Robert A de Man, Heiner Wedemeyer, et al.
Scientific Reports|July 25, 2019
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levelsKostandinos Sideras, Robert A de Man, Susan M Harrington, et al.
Pageof 48